Schott Pharma — Director's Dealing 2024

Mar 4, 2024

News Details

Directors’ Dealings | 4 March 2024 16:02

SCHOTT Pharma AG & Co. KGaA: Dr. Jens Schulte, sell

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

04.03.2024 / 16:02 CET/CEST

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:	Dr.
First name:	Jens
Last name(s):	Schulte

2. Reason for the notification

a) Position / status

Position:	Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

SCHOTT Pharma AG & Co. KGaA

b) LEI

529900TU48UE99NHEY88

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A3ENQ51

b) Nature of the transaction

Disposal

c) Price(s) and volume(s)

Price(s)	Volume(s)
40.0000 EUR	80,000.00 EUR

d) Aggregated information

Price	Aggregated volume
40.0000 EUR	80,000.0000 EUR

e) Date of the transaction

2024-03-01; UTC+1

f) Place of the transaction

Name:	Xetra
MIC:	XETR

---

04.03.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---

Language:	English
Company:	SCHOTT Pharma AG & Co. KGaA
	Hattenbergstraße 10
	55122 Mainz
	Germany

End of News	EQS News Service